Harbin Pharmaceutical Group Co Ltd (600664) — Free Cash Flow Generation Index
Harbin Pharmaceutical Group Co Ltd (600664) has a Free Cash Flow Generation Index of 0.94x as of June 2025. Free cash flow of CN¥302.84 Million represents 1% of operating cash flow (CN¥323.33 Million). See Harbin Pharmaceutical Group Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1998–2024)
Historical FCF Generation Index trend for Harbin Pharmaceutical Group Co Ltd across 23 annual periods. Explore 600664 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year Free Cash Flow Generation Index for Harbin Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see 600664 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.87x | CN¥691.69 Million | CN¥792.50 Million | CN¥100.81 Million | ▼ -4.0% |
| 2023 | 0.91x | CN¥863.14 Million | CN¥949.67 Million | CN¥86.54 Million | ▲ +6.2% |
| 2022 | 0.86x | CN¥532.45 Million | CN¥622.09 Million | CN¥89.65 Million | ▲ +2.5% |
| 2018 | 0.84x | CN¥578.61 Million | CN¥692.72 Million | CN¥114.11 Million | ▲ +164.0% |
| 2017 | 0.32x | CN¥47.21 Million | CN¥149.22 Million | CN¥102.01 Million | ▼ -67.1% |
| 2016 | 0.96x | CN¥2.67 Billion | CN¥2.78 Billion | CN¥107.46 Million | ▲ +16.5% |
| 2015 | 0.82x | CN¥1.37 Billion | CN¥1.66 Billion | CN¥290.75 Million | ▲ +23.2% |
| 2014 | 0.67x | CN¥760.73 Million | CN¥1.14 Billion | CN¥375.37 Million | ▲ +141.6% |
| 2013 | -1.61x | CN¥-228.26 Million | CN¥141.64 Million | CN¥369.90 Million | ▼ -418.7% |
| 2012 | 0.51x | CN¥282.05 Million | CN¥557.83 Million | CN¥275.78 Million | ▼ -31.7% |
| 2010 | 0.74x | CN¥853.47 Million | CN¥1.15 Billion | CN¥299.19 Million | ▼ -15.8% |
| 2009 | 0.88x | CN¥1.63 Billion | CN¥1.85 Billion | CN¥223.26 Million | ▲ +16.8% |
| 2008 | 0.75x | CN¥435.50 Million | CN¥578.59 Million | CN¥143.09 Million | ▲ +3.0% |
| 2007 | 0.73x | CN¥475.17 Million | CN¥650.16 Million | CN¥175.00 Million | ▲ +31.0% |
| 2006 | 0.56x | CN¥411.81 Million | CN¥738.08 Million | CN¥326.28 Million | ▲ +34.6% |
| 2005 | 0.41x | CN¥314.15 Million | CN¥757.76 Million | CN¥443.61 Million | ▲ +122.1% |
| 2004 | -1.88x | CN¥-279.59 Million | CN¥149.01 Million | CN¥428.60 Million | ▼ -232.5% |
| 2003 | -0.56x | CN¥-170.89 Million | CN¥302.83 Million | CN¥473.73 Million | ▼ -2752.2% |
| 2002 | -0.02x | CN¥-7.59 Million | CN¥383.44 Million | CN¥391.03 Million | ▲ +61.6% |
| 2001 | -0.05x | CN¥-31.15 Million | CN¥604.13 Million | CN¥635.28 Million | ▲ +31.5% |
| 2000 | -0.08x | CN¥-40.80 Million | CN¥541.70 Million | CN¥582.49 Million | ▼ -113.2% |
| 1999 | 0.57x | CN¥246.79 Million | CN¥431.22 Million | CN¥184.43 Million | ▲ +5.0% |
| 1998 | 0.55x | CN¥120.69 Million | CN¥221.41 Million | CN¥100.73 Million | — |